Having long flagged 2022 as the biggest year of their conversational commerce platform, artificial intelligence company Crowd Media (ASX: CM8) has bolstered its Board of Directors with the appointment of Sytze Voulon who most recently oversaw an $885 million merger. Appointed CEO of Synlab Analytics & Services in 2019, Voulon led the division of Synlab
Read More
The best tech often has a rival, another company doing similar work. Healthy competition puts consumers in prime position as companies battle it out to sweeten the deal and get you to hand over your precious cash. iPhone people and Android people are almost two different social subclasses. So are sleek Mac users and practical
Read More
The ball is now rolling for medicinal cannabis company MGC Pharma (ASX: MXC) for their entry into the United States, having received their first orders from AMC Holdings as part of plans to fast-track regulatory approval for phytocannabinoid-derived medicines in the US. The order is for 1000 units of CimetrA™ which are manufactured at MGC’s
Read More
Pets are family. The staffy cross under my desk who lives here rent free will attest to that. Our fur children are exactly that, children. With little personalities, quirks, likes and dislikes it’s hard not to think of the four legged friend you share your space with as more than a dog. Numerous studies have
Read More
The awkward sibling to Australia’s largest stock exchange could soon be mixing with a new crowd with the National Securities Exchange (ASX: NSX) commencing discussions with a Middle Eastern conglomerate to explore a new exchange in the Kingdom of Saudi Arabia. The discussions come in the form of a Memorandum of Understanding with Saudi-based Abilitii
Read More
“Published” is an accolade that many scientists strive for. Showcasing your work and communicating your results to peers feels good, regardless of age. The setting of scientific show and tell is within scientific journals, offering an enduring record of a scientist’s findings and impact on the world (vastly less obtrusive than being sat down and
Read More
Within the changing landscape of professional development, the popularity of online meetings has accelerated the global expansion of human resources tech company AD1 (ASX: AD1) to expand their online mentoring platform, Art of Mentoring, globally via a partnership with HR.com. By linking up with HR.com, Art of Mentoring will provide mentoring programs for HR professionals
Read More
Given the impressive portfolio growth that Healthia (ASX: HLA) has delivered over the past three years, institutional investors have been keen for more of the allied health company with many missing out on their latest capital raise which was heavily oversubscribed. Making Healthia attractive has been the continued growth of their allied health network which
Read More
Vital signs are important indicators of health, however, they often don’t show the whole picture. Technological advancements in the medtech world are equipping clinicians with valuable, detailed insights into their patients’ health, assisting with clinical decision making and optimising patient outcomes. With over 700 devices in clinical use worldwide, Impedimed’s (ASX: IPD) clinically validated, fully
Read More
Australian Pharmaceutical Industries (ASX: API) has become the belle of the pharmacy industry with Sigma Healthcare Limited (ASX: SIG) launching a late unsolicited offer to acquire API at a premium to the current offer on the table from retail giant Wesfarmers (ASX: WES). The bid from Sigma is a surprising one given Wesfarmers submitted their
Read More
